What Credence MedSystems does

Credence MedSystems is a private medical device and drug delivery company headquartered in Menlo Park, California, focused on proprietary injectable delivery platforms for pharmaceutical and biotechnology manufacturers. The company has operated since approximately 2011–2014 and has built a portfolio of branded syringe-based systems targeting biologics, ophthalmics, aesthetics, and global health applications. Its customer base is enterprise B2B, comprising pharma and biotech sponsors that integrate Credence's devices into combination products and branded therapeutics. The company is small (11–50 employees) and remains privately held, with cumulative funding of roughly $77.5M+ across multiple rounds and a strategic investor base that includes Novartis, Molex, and the Bill & Melinda Gates Foundation.

The product portfolio centers on the Companion® Safety Syringe System (Staked Needle and Luer variants) with enhancements including Multi-Length Staked Needle, Needle Mask, and Needle Isolation Valve; the Dual Chamber Syringe System for reconstitution and sequential delivery; the Micro-Dose™ Syringe System for ophthalmic applications; the Multi-Site™ Syringe System for aesthetics; and the Credence Connect™ connected health platform, developed in collaboration with Phillips-Medisize as a connected autoinjector. The technology is mechanical and pharmaceutical rather than data-driven, with safety, convenience, and connectivity positioned as the differentiators versus commodity syringe supply. The Dual Chamber system has been supported by a Gates Foundation grant, signaling relevance to global health reconstitution use cases.

Commercially, Credence generates revenue through custom development, licensing, and commercial supply agreements with pharma and biotech customers, leveraging contract manufacturing and fill-finish partners (Phillips-Medisize and SMC Ltd.) for scaled production rather than building in-house sterile capacity. Strategic capital from Novartis (a pharma manufacturer) and Molex (a global connector solutions provider) doubles as both funding and go-to-market validation. The company has moved from a development-stage posture to early commercial supply, with a global biopharma leader agreement for ophthalmic drug delivery announced in January 2026, and a small set of anchor customers such as Azura Ophthalmics. Customer concentration is correspondingly high, and revenue predictability depends on the trajectory of a limited number of combination product programs.

Name

Credence MedSystems

Legal name

Credence MedSystems, Inc.

Website

https://credencemed.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Credence MedSystems is a private drug delivery device company developing proprietary safety syringes, dual chamber, micro-dose, multi-site, and connected health platforms for pharmaceutical and biotechnology manufacturers.

Ownership category

akta.pro rank

Product category

Injectable Drug Delivery Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Injectable drug delivery
• Safety syringe systems
• Prefilled syringe devices
• Dual chamber syringes
• Connected injection systems

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Drug Delivery Device Sales: Credence MedSystems generates revenue through the sale of proprietary drug delivery devices and systems to pharmaceutical and biotechnology manufacturers. The company offers multiple platform products including the Companion Syringe System, Dual Chamber Syringe System, and Metered Dosing Systems. Revenue is generated from device sales, custom development partnerships, and potentially licensing of technology. Commercial supply agreements with pharmaceutical customers drive recurring revenue relationships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Credence MedSystems designs, develops, and sells proprietary injectable drug delivery devices to pharmaceutical and biotechnology manufacturers. Its portfolio includes the Companion Safety Syringe System (Staked Needle and Luer variants), Dual Chamber Reconstitution and Sequential Syringe Systems, Metered Dosing Systems (Micro-Dose, Multi-Site, Force-Assist), the Credence Connect connected health injection system, custom product development services, and prefilled pharmaceutical capabilities. The offering is built on the "Innovation Without Change" philosophy, allowing manufacturers to add safety, usability, sustainability, and connected features without disrupting existing syringe platforms or validated processes.

Product overview

Credence MedSystems offers a comprehensive portfolio of injectable drug delivery devices built on their 'Innovation Without Change®' philosophy, enabling pharmaceutical manufacturers to enhance products without disrupting existing processes. The core product families include: the Companion® Syringe System (available as Staked Needle and Luer variants) providing integrated safety and usability features; the Dual Chamber Syringe System (Reconstitution and Sequential options) for drugs requiring separate storage of constituents; Metered Dosing Products (Micro-Dose™ for ophthalmic applications, Multi-Site™ for cosmetic/therapeutic injections, and Force-Assist™ for high-viscosity formulations); and Connected Health Products (Credence Connect™ Auto-Sensing Injection System and Phillips-Medisize Connected Autoinjector). The portfolio also includes delivery system enhancements (Multi-Length Staked Needle, Needle Mask™, Needle Isolation Valve™), manual and autoinjector accessories, custom product development services, and prefilled pharmaceuticals capabilities. All products are designed to work with industry-standard syringe barrels, plunger stoppers, and needle shields.

Differentiator

Problem solved

Functional benefit

Brands

• Companion: Companion Syringe System - featuring Staked Needle and Luer options with integrated safety and usability features
• Credence Connect
• Micro-Dose
• Multi-Site
• Force-Assist
• Dual Chamber

Products and services

• Companion Staked Needle Syringe Flagship safety syringe with pre-attached (staked) needle, featuring automatic passive needle retraction, reuse prevention, and end-of-dose cues. Designed to reduce manufacturing steps and waste, accommodate high viscosity drugs, and improve sustainability versus conventional add-on safety systems. Targeted at pharmaceutical manufacturers developing injectable combination products.
• Companion Luer Syringe Luer-based variant of the Companion safety syringe system with a Guide-On Needle Cover to support proper user needle attachment. Provides passive needle retraction and end-of-dose cues while letting users attach their preferred needle, targeted at pharmaceutical manufacturers whose combination products use a Luer interface.
• Dual Chamber Reconstitution Syringe
• Dual Chamber Sequential Syringe
• Micro-Dose Syringe System
• Multi-Site Syringe System
• Credence Connect Auto-Sensing Injection System
• Connected Autoinjector (Phillips-Medisize collaboration)
• Custom Product Development
• Prefilled Pharmaceuticals

Quantifiable outcome

• 54% reduction in added component weight compared to conventional add-on safety approach
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• Global Biopharmaceutical Leader (unnamed)coreChannel Partner/ Reseller/ Distributor · 7 January 2026Commercial supply agreement announced January 7, 2026 with a global biopharmaceutical leader for ophthalmic drug delivery products. This represents Credence's first major commercial supply agreement for their drug delivery systems in the ophthalmology market segment.
• SMC Ltd. Pharma ServicescoreStrategic or Co-development Partner · 23 September 2025Collaboration announced September 23, 2025 to advance Dual Chamber fill-finish capabilities. The partnership enables Credence's dual chamber syringe device configuration to be used with SMC's contract manufacturing services, allowing an array of CMOs to perform dual chamber fill finish with modest investment and minimal changes.
• Phillips-MedisizecoreStrategic or Co-development Partner · 19 October 2021Strategic collaboration announced October 19, 2021 to develop a connected autoinjector compatible with the Credence Companion and Dual Chamber syringe systems. The collaboration leverages Phillips-Medisize's device manufacturing expertise to provide a suite of disposable and reusable autoinjectors that incorporate Credence's integrated safety and usability features.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• West Pharmaceutical Services: West Pharma is a leading provider of primary packaging and drug delivery components for injectable pharmaceuticals, including elastomeric stoppers, syringe plungers, and integrated delivery systems — directly comparable to Credence's prefilled syringe and combination-product offering.
• Gerresheimer: Gerresheimer manufactures primary packaging and drug delivery devices (syringes, vials, autoinjectors) for pharma and biotech — competing directly with Credence's syringe platforms and combination-product capabilities.
• Stevanato Group: Stevanato produces drug containment and delivery solutions including syringes, vials, and integrated devices for injectable therapeutics — overlapping with Credence's prefilled syringe and combination-product focus.
• Ypsomed: Ypsomed is a specialist developer and manufacturer of injection systems (autoinjectors, pen injectors, safety syringes) for pharmaceutical and biotech customers — directly comparable to Credence's delivery-device portfolio.
• SHL Medical: SHL Medical designs and manufactures advanced drug delivery systems including autoinjectors and pen injectors for global pharma, directly competing for injectable device programs of the type Credence targets.
• Phillips-Medisize: Phillips-Medisize is a contract developer and manufacturer of drug delivery devices (autoinjectors, connected injectors) — Credence's announced collaboration partner on connected autoinjectors and a direct peer in combination-product device manufacturing.
• Owen Mumford: Owen Mumford develops and manufactures drug delivery devices including auto-injectors, pen injectors, and safety lancets for pharmaceutical manufacturers — overlapping with Credence's safety and connected device offerings.

Broad incumbents

• Becton Dickinson (BD): BD is one of the largest manufacturers of prefilled syringes, safety syringes, and injectable drug delivery devices globally, serving the same pharmaceutical manufacturer customer base as Credence across a much broader portfolio.
• SCHOTT Pharma: SCHOTT Pharma manufactures primary packaging and drug delivery solutions (syringes, vials, ampoules, cartridges) for the global pharma industry — a broader incumbent competing with Credence across prefilled syringe platforms.
• Catalent: Catalent provides drug delivery and fill-finish services including prefilled syringe manufacturing and combination-product support — overlapping with Credence's prefilled pharmaceutical and combination-product device offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/credence-medsystems-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds9 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Credence MedSystems